filmov
tv
aml
1:30:35
The Precision Team in AML
0:04:59
Akute myeloische Leukämie (AML) über „Blut wie Milchschaum“ | Kurvenkratzer für Novartis
0:01:19
Dr. Kambhampati on the Impact of Next-Generation Sequencing in AML
0:22:21
How to Approach to Acute Myeloid Leukemia (AML) from Community Oncology Perspective
0:04:46
Acute Myeloid Leukemia (AML) Treatment Options
0:01:49
Targeting leukemic stem cells in AML
0:00:39
Acute Myeloid Leukemia (AML)
0:02:20
The complications of treating elderly patients with AML
0:03:34
Treating patients with AML who are ineligible for intensive chemotherapy
0:33:29
Higher-risk MDS and AML: How new guidelines are changing diagnosis, classification and management
0:00:33
Acute myeloid leukemia (AML)
0:02:02
What are induction and consolidation chemotherapy for AML?
0:02:11
Future prospects for CAR-T cell therapy in AML
0:01:03
What is secondary acute myeloid leukemia, or secondary AML?
0:00:47
How cancer grows #AML
0:29:07
Newly diagnosed AML: Hitting the right target
0:02:41
Immunotherapy in AML: azacitidine plus checkpoint inhibitors
0:01:53
Insights into the German AML study group
0:03:54
30-Year Acute Myeloid Leukemia Survivor Shares His Journey
0:12:21
Beat AML: A Precision Medicine Approach to Treat Acute Myeloid Leukemia
0:01:39
Akut Miyeloid Lösemi (AML) Belirtileri Nelerdir?
0:02:38
FLT3 inhibitors: revolutionizing the management of AML
0:00:57
#shorts Was ist eine akute myeloische Leukämie (AML)?
0:04:34
The Genetics of Acute Myeloid Leukemia (AML)
Назад
Вперёд
1:30:35
0:04:59
0:01:19
0:22:21
0:04:46
0:01:49
0:00:39
0:02:20
0:03:34
0:33:29
0:00:33
0:02:02
0:02:11
0:01:03
0:00:47
0:29:07
0:02:41
0:01:53
0:03:54
0:12:21
0:01:39
0:02:38
0:00:57
0:04:34